Alkem Laboratories ke liye badi khushkhabri hai! US FDA ne Mandva API facility ka inspection pura kar liya hai aur unhe 'Zero Observations' (Form 483) mile hain, matlab sab kuch perfect hai.
FDA inspection mein hua kamaal
Alkem Laboratories ki Mandva API facility ka inspection 30 October 2026 ko complete hua aur result ekdum positive raha. US FDA ki team ne yahan koi bhi issue nahi paya, jise 'Zero Observations' kehte hain. Industry mein ise ek ideal audit result mana jata hai.
Investors ke liye kyun hai ye badi baat?
Pharma sector mein US FDA ki compliance sabse badi tension hoti hai. Agar koi 'Form 483' mil jata, toh import alerts ya production rukne ka risk rehta hai. Lekin yahan sab kuch clear hone se, company ka US markets mein supply chain ab bina kisi hurdle ke chalta rahega.
Aage kya track karein?
Filhal sab positive hai, par investors ko ab Establishment Inspection Report (EIR) ka wait karna chahiye. Jab ye formal document aa jayega, tabhi samjho ki FDA ne official taur par apna inspection cycle close kar diya hai.